DCR BioReG Update

Posted by: DaVita Clinical Research

  The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more

Nephrology Research: How Will We Find a Cure?

Posted by: DaVita Clinical Research

Chances are that you or someone you know has faced a cancer diagnosis.  It’s also likely that after a diagnosis, the possibility of participating in clinical trials was highlighted. For… Read more

Enrolling Dialysis Patients for Clinical Trials

Posted by: DaVita Clinical Research

Patient enrollment for clinical trials can be a challenging task especially if the patients are dealing with a chronic illness. Dialysis patients in particular are a population that need a… Read more

How Biosimilars Could Impact Clinical Trials

Posted by: DaVita Clinical Research

Over the next few years, the patents for many therapeutic biologics will expire, allowing drug manufacturers to request US Food and Drug Administration (FDA) approval for biosimilars, medical products which… Read more

E-Consent in a Phase 1 Setting

Posted by: DaVita Clinical Research

Informed consent to participation in a clinical trial involves substantially more than obtaining signatures from subjects on a written form. It includes providing to potential participants enough information about the… Read more

Why use a Specialty Full Service CRO?

Posted by: DaVita Clinical Research

A common trend in the drug development industry is to utilize data and innovation to safely begin participant involvement earlier and earlier in clinical trials.  As innovation continues to be… Read more